Contrarily, in patients with AML, the upregulation of the inhibitory receptor CD94/NKG2A on NK cells may be responsible for their diminished effector function, reducing the possibility of complete remission after chemotherapy [38]. Here, KLRC1 is linked to acute myeloid leukemia.